Learning objectives

• Describe the current limitations of HFmrEF/HFpEF GDMT in advanced patients
• Select appropriate patients for advanced medical therapy
• Recall recent trial data for novel therapeutic approaches
• Use expert guidance to develop an evidence-based approach to managing advanced HFmrEF/HFpEF